A detailed history of Macquarie Group LTD transactions in Incyte Corp stock. As of the latest transaction made, Macquarie Group LTD holds 112,325 shares of INCY stock, worth $9.05 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
112,325
Previous 161,584 30.49%
Holding current value
$9.05 Million
Previous $9.21 Million 26.03%
% of portfolio
0.01%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$51.18 - $63.75 $2.52 Million - $3.14 Million
-49,259 Reduced 30.49%
112,325 $6.81 Million
Q1 2024

May 14, 2024

SELL
$56.55 - $66.59 $962,311 - $1.13 Million
-17,017 Reduced 9.53%
161,584 $9.21 Million
Q4 2023

Feb 14, 2024

BUY
$52.16 - $64.19 $609,541 - $750,124
11,686 Added 7.0%
178,601 $11.2 Million
Q3 2023

Nov 14, 2023

BUY
$57.77 - $65.93 $4.19 Million - $4.78 Million
72,453 Added 76.7%
166,915 $9.64 Million
Q2 2023

Aug 14, 2023

SELL
$60.95 - $75.51 $1.52 Million - $1.89 Million
-24,991 Reduced 20.92%
94,462 $5.88 Million
Q1 2023

May 15, 2023

BUY
$70.23 - $86.01 $404,454 - $495,331
5,759 Added 5.07%
119,453 $8.63 Million
Q4 2022

Feb 21, 2023

SELL
$67.18 - $84.11 $1.4 Million - $1.75 Million
-20,842 Reduced 15.49%
113,694 $9.13 Million
Q3 2022

Nov 14, 2022

SELL
$66.18 - $82.86 $33,420 - $41,844
-505 Reduced 0.37%
134,536 $8.97 Million
Q2 2022

Aug 15, 2022

SELL
$66.18 - $83.18 $93,710 - $117,782
-1,416 Reduced 1.04%
135,041 $10.3 Million
Q1 2022

May 16, 2022

BUY
$66.02 - $79.71 $575,628 - $694,991
8,719 Added 6.83%
136,457 $10.8 Million
Q4 2021

Feb 11, 2022

SELL
$63.34 - $74.11 $1.48 Million - $1.73 Million
-23,407 Reduced 15.49%
127,738 $9.38 Million
Q3 2021

Nov 12, 2021

SELL
$68.67 - $84.02 $353,375 - $432,366
-5,146 Reduced 3.29%
151,145 $10.4 Million
Q2 2021

Aug 13, 2021

BUY
$79.87 - $87.53 $2.49 Million - $2.73 Million
31,159 Added 24.9%
156,291 $13.1 Million
Q1 2021

May 14, 2021

SELL
$76.02 - $100.5 $190,430 - $251,752
-2,505 Reduced 1.96%
125,132 $10.2 Million
Q3 2020

Nov 13, 2020

BUY
$85.07 - $109.69 $3.28 Million - $4.22 Million
38,499 Added 43.19%
127,637 $11.5 Million
Q2 2020

Aug 11, 2020

SELL
$74.18 - $108.93 $221,353 - $325,047
-2,984 Reduced 3.24%
89,138 $9.27 Million
Q1 2020

May 15, 2020

BUY
$63.18 - $85.97 $1.68 Million - $2.29 Million
26,622 Added 40.64%
92,122 $6.75 Million
Q4 2019

Feb 14, 2020

SELL
$73.04 - $95.72 $21,912 - $28,716
-300 Reduced 0.46%
65,500 $5.72 Million
Q3 2019

Nov 14, 2019

BUY
$72.82 - $86.52 $240,305 - $285,516
3,300 Added 5.28%
65,800 $4.89 Million
Q2 2019

Aug 14, 2019

BUY
$73.52 - $88.7 $80,872 - $97,570
1,100 Added 1.79%
62,500 $5.31 Million
Q1 2019

May 15, 2019

BUY
$63.56 - $88.17 $69,916 - $96,987
1,100 Added 1.82%
61,400 $5.28 Million
Q4 2018

Feb 15, 2019

SELL
$58.5 - $69.94 $5,850 - $6,994
-100 Reduced 0.17%
60,300 $3.83 Million
Q2 2018

Aug 14, 2018

SELL
$60.85 - $83.98 $2.91 Million - $4.01 Million
-47,800 Reduced 44.18%
60,400 $4.05 Million
Q1 2018

May 11, 2018

BUY
$83.06 - $100.98 $3.5 Million - $4.26 Million
42,153 Added 63.82%
108,200 $9.02 Million
Q4 2017

Feb 15, 2018

SELL
$93.56 - $116.6 $99,734 - $124,295
-1,066 Reduced 1.59%
66,047 $6.38 Million
Q3 2017

Nov 08, 2017

BUY
$109.15 - $138.27 $7.33 Million - $9.28 Million
67,113
67,113 $7.84 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $17.9B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.